247 related articles for article (PubMed ID: 8824536)
1. Medroxyprogesterone acetate accelerates the development and increases the incidence of mouse mammary tumors induced by dimethylbenzanthracene.
Aldaz CM; Liao QY; LaBate M; Johnston DA
Carcinogenesis; 1996 Sep; 17(9):2069-72. PubMed ID: 8824536
[TBL] [Abstract][Full Text] [Related]
2. Natural and synthetic progestins accelerate 7,12-dimethylbenz[a]anthracene-initiated mammary tumors and increase angiogenesis in Sprague-Dawley rats.
Benakanakere I; Besch-Williford C; Schnell J; Brandt S; Ellersieck MR; Molinolo A; Hyder SM
Clin Cancer Res; 2006 Jul; 12(13):4062-71. PubMed ID: 16818706
[TBL] [Abstract][Full Text] [Related]
3. Allelotypic and cytogenetic characterization of chemically induced mouse mammary tumors: high frequency of chromosome 4 loss of heterozygosity at advanced stages of progression.
Aldaz CM; Liao QY; Paladugu A; Rehm S; Wang H
Mol Carcinog; 1996 Nov; 17(3):126-33. PubMed ID: 8944072
[TBL] [Abstract][Full Text] [Related]
4. Induction of mammary cancer and lymphoma by multiple, low oral doses of 7,12-dimethylbenz[a]anthracene in SENCAR mice.
Qing WG; Conti CJ; LaBate M; Johnston D; Slaga TJ; MacLeod MC
Carcinogenesis; 1997 Mar; 18(3):553-9. PubMed ID: 9067556
[TBL] [Abstract][Full Text] [Related]
5. DMBA induced mouse mammary tumors display high incidence of activating Pik3caH1047 and loss of function Pten mutations.
Abba MC; Zhong Y; Lee J; Kil H; Lu Y; Takata Y; Simper MS; Gaddis S; Shen J; Aldaz CM
Oncotarget; 2016 Sep; 7(39):64289-64299. PubMed ID: 27588403
[TBL] [Abstract][Full Text] [Related]
6. Synthetic progestins differentially promote or prevent 7,12-dimethylbenz(a)anthracene-induced mammary tumors in sprague-dawley rats.
Benakanakere I; Besch-Williford C; Carroll CE; Hyder SM
Cancer Prev Res (Phila); 2010 Sep; 3(9):1157-67. PubMed ID: 20699413
[TBL] [Abstract][Full Text] [Related]
7. Effects of dietary apigenin on tumor latency, incidence and multiplicity in a medroxyprogesterone acetate-accelerated 7,12-dimethylbenz(a)anthracene-induced breast cancer model.
Mafuvadze B; Cook M; Xu Z; Besch-Williford CL; Hyder SM
Nutr Cancer; 2013; 65(8):1184-91. PubMed ID: 24127693
[TBL] [Abstract][Full Text] [Related]
8. Mammary carcinogenesis induced by N-methyl-N-nitrosourea (MNU) and medroxyprogesterone acetate (MPA) in BALB/c mice.
Pazos P; Lanari C; Meiss R; Charreau EH; Pasqualini CD
Breast Cancer Res Treat; 1992 Jan; 20(2):133-8. PubMed ID: 1554889
[TBL] [Abstract][Full Text] [Related]
9. Additive inhibitory effects of bromocryptine (CB-154) and medroxyprogesterone acetate (MPA) on dimethylbenz[a]anthracene (DMBA)-induced mammary tumors in the rat.
Dauvois S; Spinola PG; Labrie F
Eur J Cancer Clin Oncol; 1989 May; 25(5):891-7. PubMed ID: 2525471
[TBL] [Abstract][Full Text] [Related]
10. Inhibitory effects of medroxyprogesterone acetate (MPA) and the pure antiestrogen EM-219 on estrone (E1)-stimulated growth of dimethylbenz(a)anthracene (DMBA)-induced mammary carcinoma in the rat.
Li S; Lévesque C; Geng CS; Yan X; Labrie F
Breast Cancer Res Treat; 1995 May; 34(2):147-59. PubMed ID: 7647332
[TBL] [Abstract][Full Text] [Related]
11. Induction of mammary tumors in virgin female BALB/c mice by single low doses of 7,12-dimethylbenz[a]anthracene.
Ethier SP; Ullrich RL
J Natl Cancer Inst; 1982 Nov; 69(5):1199-203. PubMed ID: 6813553
[TBL] [Abstract][Full Text] [Related]
12. Progesterone induction of mammary carcinomas in BALB/c female mice. Correlation between progestin dependence and morphology.
Kordon EC; Molinolo AA; Pasqualini CD; Charreau EH; Pazos P; Dran G; Lanari C
Breast Cancer Res Treat; 1993 Oct; 28(1):29-39. PubMed ID: 8123867
[TBL] [Abstract][Full Text] [Related]
13. Exposure of Sprague-Dawley rats to a 50-Hertz, 100-microTesla magnetic field for 27 weeks facilitates mammary tumorigenesis in the 7,12-dimethylbenz[a]-anthracene model of breast cancer.
Thun-Battersby S; Mevissen M; Löscher W
Cancer Res; 1999 Aug; 59(15):3627-33. PubMed ID: 10446973
[TBL] [Abstract][Full Text] [Related]
14. Curcumin delays development of medroxyprogesterone acetate-accelerated 7,12-dimethylbenz[a]anthracene-induced mammary tumors.
Carroll CE; Benakanakere I; Besch-Williford C; Ellersieck MR; Hyder SM
Menopause; 2010; 17(1):178-84. PubMed ID: 19629015
[TBL] [Abstract][Full Text] [Related]
15. Synergistic effect of MNU and DMBA in mammary carcinogenesis and H-ras activation in female Sprague-Dawley rats.
Shirai K; Uemura Y; Fukumoto M; Tsukamoto T; Pascual R; Nandi S; Tsubura A
Cancer Lett; 1997 Nov; 120(1):87-93. PubMed ID: 9570390
[TBL] [Abstract][Full Text] [Related]
16. Controlled release low dose medroxyprogesterone acetate (MPA) inhibits the development of mammary tumors induced by dimethyl-benz(a) anthracene in the rat.
Labrie F; Li S; Bélanger A; Côté J; Mérand Y; Lepage M
Breast Cancer Res Treat; 1993; 26(3):253-65. PubMed ID: 8251650
[TBL] [Abstract][Full Text] [Related]
17. Apparent rat strain-related sensitivity to phorbol promotion of mammary carcinogenesis.
Shellabarger CJ; Holtzman S; Stone JP
Cancer Res; 1979 Sep; 39(9):3345-8. PubMed ID: 113089
[TBL] [Abstract][Full Text] [Related]
18. Effect of medroxyprogesterone acetate on the response of the rat mammary gland to carcinogenesis.
Russo IH; Gimotty P; Dupuis M; Russo J
Br J Cancer; 1989 Feb; 59(2):210-6. PubMed ID: 2522791
[TBL] [Abstract][Full Text] [Related]
19. Promoter effect of medroxyprogesterone acetate (MPA) in N-methyl-N-nitrosourea (MNU) induced mammary tumors in BALB/c mice.
Pazos P; Lanari C; Elizalde P; Montecchia F; Charreau EH; Molinolo AA
Carcinogenesis; 1998 Mar; 19(3):529-31. PubMed ID: 9525291
[TBL] [Abstract][Full Text] [Related]
20. Influence of caffeine on development of benign and carcinomatous mammary gland tumors in female rats treated with the carcinogens 7,12-dimethylbenz(a)anthracene and N-methyl-N-nitrosourea.
VanderPloeg LC; Wolfrom DM; Welsch CW
Cancer Res; 1991 Jul; 51(13):3399-404. PubMed ID: 1905195
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]